Practical Tips If Your Provider Says Occasional Alcohol Is Okay If your healthcare provider says occasional alcohol is reasonable for you, use caution
They may have to determine if the interaction is worth the benefit of using both drugs or if your therapeutic plan needs to be changed
You can begin with a brief online assessment to determine if treatment is suitable for you.
News provided by Novo Nordisk Jul 01, 2026, 07:00 ET Starting today, eligible Medicare patients living with obesity can access Wegovy (semaglutide) injection and pill for a $50 monthly copay Wegovy offers adults living with obesity significant weight loss, along with diet and exercise, and is FDA-approved to lower the risk of major cardiovascular events including death, heart attack, or stroke in adults with obesity and heart disease a claim only Wegovy can make Since launching in January 2026, Wegovy pill has reached 3 million prescriptions * Medicare GLP-1 Bridge participation now expands patient access to authentic, FDA-approved Wegovy , including the Wegovy pill PLAINSBORO, N.J., July 1, 2026 /PRNewswire/ -- Starting today FDA-approved Wegovy (semaglutide) is available through the Medicare GLP-1 Bridge, a new access pathway for millions of older adults living with obesity

Candidates Most patients who want to sculpt their jawline or eliminate a double chin without surgery are suitable candidates for a fat-dissolving injection
its role is largely limited to ensuring accurate labeling and responding to reports of adverse effects